Urinary prostaglandin D synthase (uPGDS) has been identified as a biomarker in lupus nephritis (LN) mice model as well as in humans. We studied the effect of therapy for LN on its levels in a longitudinal study and its ability to differentiate between active systemic lupus erythematosus (SLE) patients with and without nephritis.